Close Menu
New York Examiner News

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Truth & Movies Special: Nathan Fielder Studies

    November 21, 2026

    Tammy Slatons Fiancée Attempting Damage Control After Using Racial Slur

    November 21, 2026

    Every Song Across All 24 Radio Stations in Grand Theft Auto VI

    November 20, 2026
    Facebook X (Twitter) Instagram
    New York Examiner News
    • Home
    • US News
    • Politics
    • Business
    • Science
    • Technology
    • Lifestyle
    • Music
    • Television
    • Film
    • Books
    • Contact
      • About
      • Amazon Disclaimer
      • DMCA / Copyrights Disclaimer
      • Terms and Conditions
      • Privacy Policy
    New York Examiner News
    Home»Business»CDC endorses updated COVID boosters that target Omicron strains, clearing the way for shots to begin soon  
    Business

    CDC endorses updated COVID boosters that target Omicron strains, clearing the way for shots to begin soon  

    By AdminSeptember 2, 2022
    Facebook Twitter Pinterest LinkedIn WhatsApp Email Reddit Telegram
    CDC endorses updated COVID boosters that target Omicron strains, clearing the way for shots to begin soon  

    [ad_1]

    New COVID-19 boosters that target today’s most common omicron strains are set to begin soon after the Centers for Disease Control and Prevention endorsed the updated shots Thursday.

    The decision by CDC Director Rochelle Walensky came shortly after the agency’s advisers said if enough people roll up their sleeves, the shots could blunt a winter surge.

    “They can help restore protection that has waned since previous vaccination and were designed to provide broader protection,” she said in a statement.

    The tweaked shots made by Pfizer and rival Moderna offer Americans a chance to get the most up-to-date protection at yet another critical period in the pandemic. They’re combination or “bivalent” shots — half the original vaccine and half protection against the BA.4 and BA.5 omicron versions now causing nearly all COVID-19 infections.

    The CDC’s advisers struggled with who should get the new booster and when because only a similarly tweaked vaccine, not the exact recipe, has been studied in people so far.

    But ultimately the panel deemed it the best option considering the U.S. still is experiencing tens of thousands of COVID-19 cases and about 500 deaths every day — even before an expected new winter wave.

    “I think they’re going to be an effective tool for disease prevention this fall and into the winter,” said CDC adviser Dr. Matthew Daley of Kaiser Permanente Colorado.

    Comparing the tweak that has been studied in people and the one the U.S. actually will use, “it is the same scaffolding, part of the same roof, we’re just putting in some dormers and windows,” said Dr. Sarah Long of Drexel University.

    The CDC is expected to adopt that recommendation soon, the last step before shots can begin. Pfizer said it expected to deliver 3 million doses to vaccination sites around the country by Tuesday.

    The original COVID-19 vaccines still offer strong protection against severe illness and death, especially among younger and healthier people who’ve gotten at least one booster.

    But those vaccines were designed to target the virus strain that circulated in early 2020. Effectiveness drops as new mutants emerge and more time passes since someone’s last shot. Since April, hospitalization rates in people over age 65 have jumped, the CDC said.

    The new updated shots are only for use as a booster, not for someone’s first-ever vaccinations. The Food and Drug Administration cleared Pfizer’s bivalent option for people 12 and older while Moderna’s is for adults only.

    A big unknown: exactly how much benefit people will get from one of those extra shots.

    The CDC said more than 1,400 people have been included in several studies of a prior tweak to the vaccine recipe targeting an earlier omicron strain named BA.1. That omicron-targeting combo shot proved safe and able to rev up virus-fighting antibodies, and European regulators on Thursday recommended using that type of booster.

    In the U.S., the FDA wanted fall boosters to target the currently circulating omicron strains. Rather than waiting until possibly November for more human studies to be finished, the agency accepted mouse testing that showed the newer tweak sparked a similarly good immune response.

    That’s how flu vaccines are updated every year, the CDC noted.

    Dr. Pablo Sanchez of the Ohio State University was the only CDC adviser to vote against recommending the shots. He said he believes the bivalent vaccine is safe and that he likely will get it.

    But “I just feel that this was a bit premature” given the absence of human data on how well it works, he said.

    Several CDC advisers said that to get the maximum benefit, people will need to wait longer between their last vaccination and the new booster than the two-month minimum set by the FDA. Waiting at least three months would be better, they said.

    One more change: The FDA no longer authorizes use of the original-recipe boosters for anyone 12 or older — a source of potential confusion for people who had planned on getting a regular booster this week and now may have to wait for the new kind to arrive at their local pharmacy or clinic.

    It’s not clear how many people will want an updated shot. Just half of vaccinated Americans got the first recommended booster dose, and only a third of those 50 and older who were urged to get a second booster did so.

    The U.S. government has purchased 170 million doses from both companies — shots that will be free — and the CDC said 200 million people could be eligible.

    Sign up for the Fortune Features email list so you don’t miss our biggest features, exclusive interviews, and investigations.

    [ad_2]

    Original Source Link

    Share. Facebook Twitter Pinterest LinkedIn WhatsApp Email Reddit Telegram
    Previous ArticleAmericans Erupt As Trump Says He’s Financially Supporting J6 Defendants
    Next Article Taylor Swift reveals collectable editions of ‘Midnights’ on CD and vinyl

    RELATED POSTS

    My industry wants you to gut your sales team and replace it with AI. One of my customers plans to double theirs instead | Fortune

    October 27, 2026

    The Taiwan Strait is not on the verge of war: The 2027 invasion countdown is a mirage | Fortune

    October 27, 2026

    Twilio CMO: We shrank 2 weeks of work down to one day with AI. Then the unsexy work began | Fortune

    October 26, 2026

    Goldman Sachs CEO David Solomon on AIs economic impact: Theres very little that we do where we need frontier models | Fortune

    October 26, 2026

    Nasdaq CEO calls for a national strategy as global fraud losses reach $579B | Fortune

    October 25, 2026

    Michael Burry of The Big Short was asked to give advice to Gen Z: Buy half the house you can afford, and If it flies or floats, rent it | Fortune

    October 25, 2026
    latest posts

    Truth & Movies Special: Nathan Fielder Studies

    In this episode, Leila Latif, Hannah Strong and David Jenkins look back to the Canadian…

    Tammy Slatons Fiancée Attempting Damage Control After Using Racial Slur

    November 21, 2026

    Every Song Across All 24 Radio Stations in Grand Theft Auto VI

    November 20, 2026

    WGA Screenwriter Matt Allen Is Giving Away a Free Feature Rough Draft

    November 20, 2026

    Trump, Putin & Xis New Photo Op Looks Like This Classic 90s Album: Heres How the Internet Is Reacting

    November 20, 2026

    Six AI-powered gadgets that could make your home office smarter | TechCrunch

    November 20, 2026

    Bo Derek Is Still a 10 at 70: It All Worked Out, Didnt It?

    November 20, 2026
    Categories
    • Books (1,594)
    • Business (6,481)
    • Events (85)
    • Film (6,458)
    • Lifestyle (4,506)
    • Music (6,592)
    • Politics (6,448)
    • Science (5,860)
    • Technology (6,448)
    • Television (6,150)
    • Uncategorized (1)
    • US News (6,493)
    popular posts

    Mushroom Group’s Dean McLachlan Announces Retirement

    [ad_1] MELBOURNE, Australia — After 30 years with Mushroom Group, and upwards of four decades…

    Gamers might benefit from the crypto crash as demand for GPUs falls

    June 17, 2022

    The Trump Administration Wants to Change Public Engagement Rules for Polluters

    July 23, 2026

    Researchers tracked $80 million in political ads using AI—and Republicans were behind 83% of them

    October 6, 2026
    Archives
    Browse By Category
    • Books (1,594)
    • Business (6,481)
    • Events (85)
    • Film (6,458)
    • Lifestyle (4,506)
    • Music (6,592)
    • Politics (6,448)
    • Science (5,860)
    • Technology (6,448)
    • Television (6,150)
    • Uncategorized (1)
    • US News (6,493)
    About Us

    We are a creativity led international team with a digital soul. Our work is a custom built by the storytellers and strategists with a flair for exploiting the latest advancements in media and technology.

    Most of all, we stand behind our ideas and believe in creativity as the most powerful force in business.

    What makes us Different

    We care. We collaborate. We do great work. And we do it with a smile, because we’re pretty damn excited to do what we do. If you would like details on what else we can do visit out Contact page.

    Our Picks

    Six AI-powered gadgets that could make your home office smarter | TechCrunch

    November 20, 2026

    Bo Derek Is Still a 10 at 70: It All Worked Out, Didnt It?

    November 20, 2026

    Are You Under Attack By Howard Bloom

    November 20, 2026
    © 2026 New York Examiner News. All rights reserved. All articles, images, product names, logos, and brands are property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Terms & Conditions and Privacy Policy.

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
    Cookie SettingsAccept All
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT